Baby boomers, who abused their ears with rock concerts and headphones, are surging into retirement. The hearing-assistance market is expanding, and this time the answer may not be a device—it may be a pill.

LISTEN UP, baby boomers (and others): Your damaged hearing may soon be improved—and it won’t require inserting a beige gizmo in your ear. Advances in molecular biology and bioinformatics have led to an explosion of research on the causes of hearing loss and how to fix it with drugs or gene therapy.

A crop of young biotech companies is sprouting up to develop medicines. Last fall, Boston-based Third Rock Ventures launched a startup

You're reading a preview, sign up to read more.

More from Fortune

Fortune3 min read
An Adventure With Purpose
Ecotourism is increasingly trendy, but this African safari operator has been walking the walk for 35 years.
Fortune15 min readSociety
01 Bill + Melinda Gates
IT WAS MARCH 2018, AND ONCE MORE BILL GATES found himself behind a podium. In the previous few months, he had given one keynote address after another—in San Francisco, he’d urged drugmakers to focus on diseases that affect the poor as well as the ric
Fortune5 min read
Raising Superwomen
Despite her own powerful brood, Silicon Valley godmother Esther Wojcicki believes leaders are made, not born.